Exo Debuts New Point-of-Care Ultrasound Modality
The Exo Iris reportedly combines advanced silicon technology with imaging, workflow software and artificial intelligence (AI) to facilitate multidisciplinary use of point-of-care ultrasound.
Emphasizing ease of use, enhanced imaging quality and artificial intelligence features, Exo has launched the Exo Iris point-of-care ultrasound modality.
In addition to acquiring images with a sweep of one’s wrist via patented SweepAI™ technology, the Exo Iris blends silicon technology with piezoelectric crystals to facilitate rapid delivery of image quality, according to Exo.
The company said other features of Exo Iris include the ability of the ultrasound platform to provide multi-organ scans, assess fine structures and offer guidance for IVs and line procedures.
Key AI features include assessment of bladder volume in seconds with Bladder AI and forthcoming real-time guidance and triage capabilities with Cardiac and Lung AI suites that are pending FDA 510(k) clearance, according to Exo.
“Exo Iris delivers an entirely new approach to the design of ultrasound; one that doesn’t look at ultrasound as a device-only purchase, but seamlessly brings together a complete solution that includes imaging, workflow, and real-time AI in one platform,” noted Arun Nagdev, M.D., the senior director of clinical education at Exo.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
